Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Trisalus Life Sciences, Inc. (TLSI) since 2024 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Trisalus Life Sciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1826667.
Total stock buying since 2024: $842,365.
Total stock sales since 2024: $240,755.
Total stock option exercises since 2024: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 79,582 | $422,753 | 24,829 | $128,612 | 0 | $0 |
| 2024 | 98,514 | $419,612 | 30,323 | $112,143 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-05 | 0 | $0 | 24,829 | $128,612 | 0 | $0 |
| 2025-02 | 6,000 | $33,900 | 0 | $0 | 0 | $0 |
| 2025-01 | 73,582 | $388,853 | 0 | $0 | 0 | $0 |
| 2024-12 | 62,972 | $249,998 | 30,000 | $110,700 | 0 | $0 |
| 2024-11 | 15,727 | $69,806 | 0 | $0 | 0 | $0 |
| 2024-10 | 0 | $0 | 314 | $1,394 | 0 | $0 |
| 2024-09 | 19,815 | $99,808 | 0 | $0 | 0 | $0 |
| 2024-08 | 0 | $0 | 9 | $49 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-19 | Devlin Jodi (Chief of Clinical Operations) | Sale | 4,764 | 5.18 | 24,677 |
| 2025-05-19 | Marshak Richard (Chief Commercial Officer) | Sale | 6,597 | 5.18 | 34,172 |
| 2025-05-19 | Stevens Jennifer (Chief Regulatory Officer) | Sale | 8,704 | 5.18 | 45,086 |
| 2025-05-19 | Cox Bryan F. (Chief of Research) | Sale | 4,764 | 5.18 | 24,677 |
| 2025-02-05 | Young James Emmett (Chief Financial Officer) | Buy | 6,000 | 5.65 | 33,900 |
| 2025-01-30 | Szela Mary T (CEO AND PRESIDENT) | Buy | 5,010 | 5.28 | 26,452 |
| 2025-01-29 | Szela Mary T (CEO AND PRESIDENT) | Buy | 5,030 | 5.03 | 25,300 |
| 2025-01-28 | Murphy Sean (Chief Manuf, Strategy&Bus Dev.) | Buy | 15,000 | 5.17 | 77,550 |
| 2025-01-28 | Szela Mary T (CEO AND PRESIDENT) | Buy | 4,716 | 5.12 | 24,145 |
| 2025-01-27 | Young James Emmett (Chief Financial Officer) | Buy | 24,000 | 5.40 | 129,600 |
| 2025-01-27 | Murphy Sean (Chief Manuf, Strategy&Bus Dev.) | Buy | 15,000 | 5.31 | 79,650 |
| 2025-01-27 | Szela Mary T (CEO AND PRESIDENT) | Buy | 4,826 | 5.42 | 26,156 |
| 2024-12-17 | Frankenius Equity Ab | Buy | 62,972 | 3.97 | 249,998 |
| 2024-12-10 | Desai Arjun Jj | Sale | 30,000 | 3.69 | 110,700 |
| 2024-11-22 | Wahlstrom Mats | Buy | 5,000 | 4.55 | 22,750 |
| 2024-11-21 | Wahlstrom Mats | Buy | 8,687 | 4.44 | 38,570 |
| 2024-11-20 | Wahlstrom Mats | Buy | 2,040 | 4.16 | 8,486 |
| 2024-10-05 | Cox Bryan F. (CHIEF SCIENTIFIC & MANUFACT.) | Sale | 314 | 4.44 | 1,394 |
| 2024-09-13 | Szela Mary T (CEO AND PRESIDENT) | Buy | 7,295 | 4.92 | 35,854 |
| 2024-09-12 | Szela Mary T (CEO AND PRESIDENT) | Buy | 7,520 | 5.20 | 39,104 |
| 2024-09-10 | Szela Mary T (CEO AND PRESIDENT) | Buy | 5,000 | 4.97 | 24,850 |
| 2024-08-28 | Martin George Kelly | Sale | 9 | 5.50 | 49 |
Insider trading activities including stock purchases, stock sales, and option exercises of TLSI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Trisalus Life Sciences, Inc. (symbol TLSI, CIK number 1826667) see the Securities and Exchange Commission (SEC) website.